Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CATB

Catabasis Pharmaceuticals (CATB)

Catabasis Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CATB
일자시간출처헤드라인심볼기업
2023/06/0621:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/06/0621:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/05/2419:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/05/1205:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/2105:05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/2105:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/1921:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/1921:09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/04/0705:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/03/3121:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/03/2221:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1505:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1505:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1422:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/02/1420:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/01/1102:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2023/01/0522:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/2306:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/2206:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/2204:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/1607:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/12/1520:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/11/1106:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/11/1106:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
2022/11/1106:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:CATB